NJ State Employees Deferred Compensation Plan’s Amicus Therapeutics FOLD Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-17,000	Closed	-$134K	–	146
2025 Q3	$134K	Hold	17,000	–	–	0.01%	417
2025 Q2	$97.4K	Hold	17,000	–	–	0.01%	421
2025 Q1	$139K	Hold	17,000	–	–	0.02%	414
2024 Q4	$160K	Hold	17,000	–	–	0.02%	433
2024 Q3	$182K	Hold	17,000	–	–	0.02%	439
2024 Q2	$169K	Hold	17,000	–	–	0.02%	437
2024 Q1	$200K	Hold	17,000	–	–	0.03%	438
2023 Q4	$241K	Hold	17,000	–	–	0.03%	407
2023 Q3	$207K	Hold	17,000	–	–	0.03%	422
2023 Q2	$214K	Hold	17,000	–	–	0.03%	427
2023 Q1	$189K	Hold	17,000	–	–	0.03%	444
2022 Q4	$208K	Hold	17,000	–	–	0.03%	423
2022 Q3	$177K	Hold	17,000	–	–	0.03%	425
2022 Q2	$183K	Hold	17,000	–	–	0.03%	427
2022 Q1	$161K	Hold	17,000	–	–	0.02%	471
2021 Q4	$196K	Hold	17,000	–	–	0.02%	467
2021 Q3	$162K	Hold	17,000	–	–	0.02%	479
2021 Q2	$164K	Hold	17,000	–	–	0.02%	496
2021 Q1	$168K	Buy	+17,000	New	+$263K	0.02%	489
2017 Q1	–	Sell	-15,000	Closed	-$75K	–	388
2016 Q4	$75K	Hold	15,000	–	–	0.01%	362
2016 Q3	$111K	Hold	15,000	–	–	0.02%	356
2016 Q2	$82K	Hold	15,000	–	–	0.02%	365
2016 Q1	$129K	Hold	15,000	–	–	0.03%	364
2015 Q4	$146K	Hold	15,000	–	–	0.03%	365
2015 Q3	$210K	Hold	15,000	–	–	0.05%	343
2015 Q2	$212K	Hold	15,000	–	–	0.04%	350
2015 Q1	$163K	Hold	15,000	–	–	0.03%	367
2014 Q4	$125K	Hold	15,000	–	–	0.02%	373
2014 Q3	$89K	Hold	15,000	–	–	0.02%	379
2014 Q2	$50K	Hold	15,000	–	–	0.01%	386
2014 Q1	$31K	Hold	15,000	–	–	0.01%	390
2013 Q4	$35K	Hold	15,000	–	–	0.01%	425
2013 Q3	$35K	Hold	15,000	–	–	0.01%	424
2013 Q2	$35K	Buy	+15,000	New	+$46.1K	0.01%	421

Other funds holding FOLD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's FOLD Position: Q4 2025 in Review

NJ State Employees Deferred Compensation Plan sold out of Amicus Therapeutics (FOLD) in Q4 2025, closing a stake of 17,000 shares — an estimated $134K sold.

NJ State Employees Deferred Compensation Plan first reported a position in FOLD in Q2 2013 and held it in 34 quarters. The position peaked at $241K in Q4 2023. 332 funds tracked by Wall St. Rank hold FOLD as of Q4 2025.

NJ State Employees Deferred Compensation Plan reported no remaining Amicus Therapeutics position as of Q4 2025 after selling out during the quarter.
NJ State Employees Deferred Compensation Plan sold 17,000 Amicus Therapeutics shares in Q4 2025, an estimated $134K.
NJ State Employees Deferred Compensation Plan first reported a position in Amicus Therapeutics in Q2 2013 and held it in 34 quarters.
NJ State Employees Deferred Compensation Plan's Amicus Therapeutics position peaked at $241K in Q4 2023.
332 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2025.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2025.